Showing 1 to 12 of 88 results
Rising Prostate Cancer Rates in the U.S.
The American Cancer Society's 2025 report reveals a concerning rise in prostate cancer rates across all age groups in the U.S., with increases in advanced-stage cancers outpacing those in localized stages, although mortality rates have been declining, but at a slower pace.
Rising Prostate Cancer Rates in the U.S.
The American Cancer Society's 2025 report reveals a concerning rise in prostate cancer rates across all age groups in the U.S., with increases in advanced-stage cancers outpacing those in localized stages, although mortality rates have been declining, but at a slower pace.
Progress
52% Bias Score
Faster, Cheaper Prostate MRI Scan Shows Equal Accuracy
A new, faster, and cheaper MRI scan for prostate cancer diagnosis has proven equally effective as the current standard in a landmark trial, potentially increasing access to scans and improving early detection.
Faster, Cheaper Prostate MRI Scan Shows Equal Accuracy
A new, faster, and cheaper MRI scan for prostate cancer diagnosis has proven equally effective as the current standard in a landmark trial, potentially increasing access to scans and improving early detection.
Progress
48% Bias Score
Outdated Guidelines Lead to Unnecessary Prostate Cancer Treatments
Outdated National Institute for Health and Care Excellence (NICE) guidelines on prostate cancer active surveillance cause inconsistent treatment across the UK, potentially leading to 5,000 men annually undergoing unnecessary procedures and a 'postcode lottery' of care.
Outdated Guidelines Lead to Unnecessary Prostate Cancer Treatments
Outdated National Institute for Health and Care Excellence (NICE) guidelines on prostate cancer active surveillance cause inconsistent treatment across the UK, potentially leading to 5,000 men annually undergoing unnecessary procedures and a 'postcode lottery' of care.
Progress
52% Bias Score
Groundbreaking Cancer Therapy Shows Remarkable Success in Late-Stage Prostate Cancer
A California study of 15 men with late-stage prostate cancer showed that 53% achieved complete remission using SYNC-T, a novel therapy involving tumor cryotherapy followed by localized immunotherapy; this exceeded expected survival rates, offering new hope for patients with limited treatment options...
Groundbreaking Cancer Therapy Shows Remarkable Success in Late-Stage Prostate Cancer
A California study of 15 men with late-stage prostate cancer showed that 53% achieved complete remission using SYNC-T, a novel therapy involving tumor cryotherapy followed by localized immunotherapy; this exceeded expected survival rates, offering new hope for patients with limited treatment options...
Progress
48% Bias Score
Robotic Prostate Treatment Offers Hope for NI Men
Aquablation therapy, a new robotic procedure using a heat-free waterjet to remove excess prostate tissue, offers faster, less invasive treatment for enlarged prostates in Northern Ireland, improving quality of life for approximately 1,000 men on the waiting list and potentially reducing wait times f...
Robotic Prostate Treatment Offers Hope for NI Men
Aquablation therapy, a new robotic procedure using a heat-free waterjet to remove excess prostate tissue, offers faster, less invasive treatment for enlarged prostates in Northern Ireland, improving quality of life for approximately 1,000 men on the waiting list and potentially reducing wait times f...
Progress
52% Bias Score
Prostate Cancer Screening Guidelines: A Personalized Approach
The US Preventive Services Task Force recommends prostate cancer screening discussions for men aged 55-69, but not for those over 70; however, doctors recommend individual discussions with healthcare providers to weigh benefits and risks, noting potential for overtreatment and varying guidelines.
Prostate Cancer Screening Guidelines: A Personalized Approach
The US Preventive Services Task Force recommends prostate cancer screening discussions for men aged 55-69, but not for those over 70; however, doctors recommend individual discussions with healthcare providers to weigh benefits and risks, noting potential for overtreatment and varying guidelines.
Progress
48% Bias Score
Bjorn Borg's Battle with Prostate Cancer
Tennis legend Bjorn Borg, 69, revealed in his autobiography that he was diagnosed with aggressive prostate cancer in its most advanced stage, but is now in remission after surgery in 2024.
Bjorn Borg's Battle with Prostate Cancer
Tennis legend Bjorn Borg, 69, revealed in his autobiography that he was diagnosed with aggressive prostate cancer in its most advanced stage, but is now in remission after surgery in 2024.
Progress
16% Bias Score
Seattle Mariners' Playoff Hopes High Despite Questionable Pitching
Ken Griffey Jr. believes the Mariners, despite their pitching concerns, can make a deep playoff run, bolstered by stars like Julio Rodriguez and Cal Raleigh, who are exceeding expectations.
Seattle Mariners' Playoff Hopes High Despite Questionable Pitching
Ken Griffey Jr. believes the Mariners, despite their pitching concerns, can make a deep playoff run, bolstered by stars like Julio Rodriguez and Cal Raleigh, who are exceeding expectations.
Progress
24% Bias Score
NHS Over-treats 5,000 Men Annually for Prostate Cancer
The NHS overtreats approximately 5,000 men yearly for prostate cancer due to outdated guidelines, leading to unnecessary treatments and side effects; a review by Prostate Cancer UK suggests that wider adoption of monitoring instead of immediate treatment for slow-growing cancers could reduce this nu...
NHS Over-treats 5,000 Men Annually for Prostate Cancer
The NHS overtreats approximately 5,000 men yearly for prostate cancer due to outdated guidelines, leading to unnecessary treatments and side effects; a review by Prostate Cancer UK suggests that wider adoption of monitoring instead of immediate treatment for slow-growing cancers could reduce this nu...
Progress
40% Bias Score
AI Test Improves Prostate Cancer Treatment Outcomes
A new AI test predicts which men with high-risk prostate cancer will benefit from abiraterone, a drug that halves the risk of death for 25% of patients; this was tested on over 1,000 men and may lead to wider access to the drug.
AI Test Improves Prostate Cancer Treatment Outcomes
A new AI test predicts which men with high-risk prostate cancer will benefit from abiraterone, a drug that halves the risk of death for 25% of patients; this was tested on over 1,000 men and may lead to wider access to the drug.
Progress
48% Bias Score
AI Test Could Slash Prostate Cancer Deaths by Half
A new AI test identifies a biomarker in high-risk prostate cancer patients, enabling targeted abiraterone treatment; reducing the five-year death risk by 47 percent in those with the biomarker, potentially benefiting 2,100 men annually in England.
AI Test Could Slash Prostate Cancer Deaths by Half
A new AI test identifies a biomarker in high-risk prostate cancer patients, enabling targeted abiraterone treatment; reducing the five-year death risk by 47 percent in those with the biomarker, potentially benefiting 2,100 men annually in England.
Progress
48% Bias Score
Evolving Understanding and Treatment of Prostate Cancer
Professor Christoforos Logothetis, a leading prostate cancer expert, discusses the evolving understanding and treatment of the disease, emphasizing the shift from immediate surgery for all diagnoses to personalized approaches based on risk assessment and advanced technologies, as highlighted by Pres...
Evolving Understanding and Treatment of Prostate Cancer
Professor Christoforos Logothetis, a leading prostate cancer expert, discusses the evolving understanding and treatment of the disease, emphasizing the shift from immediate surgery for all diagnoses to personalized approaches based on risk assessment and advanced technologies, as highlighted by Pres...
Progress
28% Bias Score
Showing 1 to 12 of 88 results